Country’s premier medical institute, All India Institute of Medical Sciences (AIIMS) on Tuesday said that the drugs, which were used on the 49 children, were found to be “safe” and the children were also not selected from a particular socio-economic group.
Suffering from a controversy over the reports of deaths of 49 children during clinical trials of new medicines in the premier institute during the last two-and -a-half years, AIIMS said that all the studies had undergone scientific scrutiny and had all the required regulatory and ethical approvals.
According to report of the institute the infants died because they had "high-risk and serious disease conditions.